Viagra study points to possible role in slowing cancer spread...

A new study led by Israeli researchers suggests that sildenafil, the active ingredient in Viagra, could one day play a role in slowing the spread of cancer by disrupting cancer cells' access to cholesterol, a key component needed for metastasis.

The research highlights a possible mechanism by which the drug interferes with cancer cell metabolism and points to potential future applications in oncology.